KRAS and neoplasm: To examine whether the relationship between 18q LOH and CIMP status was affected by clinical or other molecular variables, we stratified tumors by sex, tumor location, p53 status or KRAS/BRAF status, and examined the frequencies of CIMP-0 in 18q LOH positive or negative tumors (Table 3).